发明名称 Biocatalytic process for preparing eslicarbazepine and analogs thereof
摘要 The present disclosure relates to biocatalysts and its uses for the efficient preparation of eslicarbazepine, eslicarbazepine acetate, and analogs thereof.
申请公布号 US9102963(B2) 申请公布日期 2015.08.11
申请号 US201214110964 申请日期 2012.04.12
申请人 Codexis, Inc. 发明人 Gohel Anupam;Smith Derek;Wong Brian;Sukumaran Joly;Yeo Wan Lin;Collier Steven J.;Novick Scott
分类号 C12P17/10;C12N9/02;C07D223/22;C07D223/28;C07D453/02;C12P41/00;C12N9/04 主分类号 C12P17/10
代理机构 Codexis, Inc. 代理人 Codexis, Inc.
主权项 1. A process for preparing a compound of structural formula (1) in enantiomeric excess,wherein each ring A and B is independently an optionally substituted monocyclic aryl or heteroaryl, R1 is selected from hydrogen, hydroxy, halo, cyano, carboxy, and an optionally substituted alkyl, aminoalkyl, cycloalkyl, heterocycloalkyl, alkyloxycarbonyl, aminocarbonyl, aminothiocarbonyl, aminosulfonyl, and sulfonyl; the process comprising contacting the compound of structural formula (2), wherein A and B, and R1 are defined above, with a ketoreductase polypeptide comprising an amino acid sequence that has at least 80% sequence identity to the reference polypeptide of SEQ ID NO: 10, wherein the amino acid sequence comprises X80 is T; X96 is V or R; X145 is L; X153 is T; X190 is P; X196 is L or M; and X226 is V, wherein the ketoreductase is capable of converting compound (2) to compound (1) in enantiomeric excess, in presence of NADH or NADPH under suitable reaction conditions.
地址 Redwood City CA US